Versigent (VGNT) Director Kevin P. Clark Sells 122,722 Shares

What Happened

• Kevin P. Clark, a director of Versigent PLC (VGNT), sold a total of 122,722 shares in open‑market transactions on September 8–9, 2026, generating approximately $5,718,565 in proceeds. The trades were all reported as sales (S) and executed under a pre-established Rule 10b5‑1 trading plan adopted June 3, 2026 through the Kevin P. Clark 2002 Revocable Trust.
• Individual tranches: 38,271 shares for $1,831,267 (weighted avg $47.85), 9,034 shares for $438,149 (weighted avg $48.50), 1,287 shares for $63,925 (weighted avg $49.67), 57,508 shares for $2,616,039 (weighted avg $45.49), 16,517 shares for $764,242 (weighted avg $46.27), and 105 shares for $4,943 (sold at $47.08).

Key Details

• Transaction dates: 2026-09-08 and 2026-09-09; Form 4 filed 2026-09-10 (timely filing).
• Prices / ranges (weighted averages; individual tranches sold across price ranges per footnotes):
  • 38,271 shares: weighted avg $47.85 (prices ranged $47.30–$48.29)
  • 9,034 shares: weighted avg $48.50 (prices ranged $48.30–$49.28)
  • 1,287 shares: weighted avg $49.67 (prices ranged $49.40–$50.12)
  • 57,508 shares: weighted avg $45.49 (prices ranged $44.99–$45.98)
  • 16,517 shares: weighted avg $46.27 (prices ranged $45.99–$46.93)
  • 105 shares: sold at $47.08
• Shares owned after transaction: Not specified in the information provided in this summary (see the Form 4 for exact post‑transaction beneficial ownership).
• Notable footnote: All sales were made pursuant to a Rule 10b5‑1 trading plan adopted June 3, 2026; several reported prices are weighted averages covering a range of execution prices (reporting person can provide detailed breakdown on request).

Context

• These were planned sales under a 10b5‑1 program, which typically indicate pre-set, periodic disposition rather than ad‑hoc selling based on current company developments. Sales do not necessarily signal a change in the insider’s view of the company; purchases are generally more informative about insider sentiment.
• Filing appears timely (Form 4 was submitted within the required reporting window). For full details, including the exact post‑transaction holdings and the trading plan terms, consult the original Form 4 (Accession 0001193125-26-388150).